Congratulations to Christina and Teresa for the article published in CMAJ
The influence of sex and gender domains on COVID-19 cases and mortality


  • Both sex (a biological attribute) and gender (a complex social construct incorporating identity, roles, relations and institutionalized gender) may influence infectious disease risk and outcomes, and severe acute respiratory syndrome coronavirus 2 appears to be no exception.
  • We found institutionalized gender inequality (as measured by the United Nations Development Project’s Gender Inequality Index) to be positively associated with the male:female ratio reported cases of coronavirus disease 2019 (COVID-19) among countries that report sex-disaggregated data; males accounted for more cases in countries with higher gender inequality.
  • Institutionalized gender and culturally entrenched roles and norms may influence who is most at risk of acquiring infection or who is able to receive a test.
  • To understand how sex and gender affect disease risk and outcomes for COVID-19 will require expanded testing and collection of relevant data; this understanding will be crucial to managing the current pandemic.


What is GOING-FWD?

Project title: Gender Outcomes INternational Group: to Further Well-being Development (GOING-FWD)

Learn more 

Educational activities

Sex and gender dimensions in education and training will include face-to-face and online modules, tools and workshops designed to improve health outcomes across non-communicable diseases. 

Learn more

We also aim to construct innovative ways to disseminate the application of gender measurement towards personalized approaches to chronic disease prevention, diagnosis and treatment.

Our research focuses on the following:

1. Gender-related variables.

2. Cost-sensitive and patient-reported outcome measures.

3. Knowledge translation and dissemination

Learn More

Workshops, Conferences and Lectures.

Learn More


Going forward Consortium integrates sex and gender dimensions in applied health research and evaluates their impact on clinical cost-sensitive outcomes and patient reported outcomes related to quality of life in noncommunicable diseases including cardiovascular disease, metabolic disease, chronic kidney disease and neurological disease (read more).

The project has been selected as the one from one of several funded by under the consortium of 16 committed organisations from 13 countries aims to strengthen transnational collaborations between research programme owners and managers, provide support to the promotion of gender equality through institutional change

This project is funded by 


Watch the Video of a patient partner Donna. Her Heart Her Story. 

What is GOING-FWD?



Workshops, Lectures, Conferences

Back to top